Clinical trials
Cancer clinical trials
Below are recruiting cancer clinical trials, each written for real people, not researchers. We’re tracking 13,118 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05706025Enrolling by invitation
Testing a capsule to screen for Barrett’s and esophageal cancer
This study checks whether a swallowable capsule can help find signs of Barrett’s esophagus or esophageal cancer (or related risk) before or around an endoscopy. The goal is to see if this less invasive sampling method could improve screening.
Aurora, ColoradoAges 45 years+ - NCT05691517RecruitingPhase 1
Test drug CBX-12 in advanced cancers and monitor your response
This Phase 1 study tests how your body handles the drug CBX-12 in people with advanced solid cancers that have already tried prior treatments. It may help researchers learn safe dosing and how tumors respond, and you may be asked to provide biopsy samples.
Bethesda, MarylandAges 18 years+ - NCT05528237Enrolling by invitation
HPV self-test to help cervical cancer screening access
This trial studies whether letting people collect their own HPV test sample (a private, at-home option) makes cervical cancer screening easier for people with HIV and/or those who are often underserved. If you’ve declined a Pap test or it’s been 6+ months since your last screening, this may offer a more convenient way to check for HPV and cervical cancer risk.
Seattle, WashingtonAges 25 years+ - NCT05524480Enrolling by invitation
Help Latina women get overdue breast, cervical care
This trial tests an implementation program that helps clinics better provide breast and cervical cancer screening and HPV vaccination to Latina women who are behind on recommended care. It may help you catch up on screening or start HPV vaccination and connect you to low-cost services.
Houston, TexasAges 18–74 - NCT05400941Enrolling by invitation
Breast cancer follow-up support in primary care
This study looks at how breast cancer follow-up care can be better done in primary care clinics. It may help by improving care check-ins and support for people who have had breast cancer and for clinic staff involved in that care.
New Brunswick, New JerseyAges 21 years+ - NCT05338866Enrolling by invitation
Chemo plus targeted high-dose radiation for low rectal cancer
This trial tests whether combining chemotherapy with high-dose radiation guided by MRI (a special scan) can better treat low rectal cancer. It may help shrink the tumor and improve local control while targeting the tumor more precisely.
Guangzhou, GuangdongAges 18–80 - NCT05213962Enrolling by invitation
Radiation after nipple-sparing mastectomy with implant
This study tests local and regional radiation treatment after nipple-sparing mastectomy done with an implant. It may help reduce cancer returning in the breast/nearby tissues for people whose cancer hasn’t spread to distant sites.
Goyang-si, Gyeonggi-doAges 20 years+ - NCT05212103Enrolling by invitation
PET scan study for specific cancers using a new tracer
This study uses a PET scan with a special radioactive tracer (68Ga-DOTA-Siglec-9) to look at cancer in certain people. It may help doctors better see cancer-related activity and guide treatment planning for selected cancers.
TurkuAges 18–100 - NCT05195515Enrolling by invitation
Study on bladder cancer late effects and quality of life
This study looks at how long-term (late) effects after bladder cancer treatment affect quality of life. You may join if you recently had blood in your urine and are being evaluated for it in a specific region of Denmark.
Aarhus NAges 18 years+ - NCT05160480Enrolling by invitation
Total-body PET scan using FDA-approved tracers for prostate or NET cancer
This pilot study tests a total-body PET scan with approved tracer medicines to help detect cancer spread in people with suspected metastatic prostate cancer or certain neuroendocrine tumors (NETs). You may be able to join if recent scans already suggest metastasis and you can safely complete the scan timing and positioning.
Sacramento, CaliforniaAges 18 years+ - NCT04534413Enrolling by invitation
Test lung cancer samples outside the body during surgery
This study looks at lung cancer tissue after surgery, using lab testing done outside the body. It may help researchers better observe and study lung tumors using samples taken during lobectomy or segment removal.
Toronto, OntarioAges 18 years+ - NCT04488614Enrolling by invitation
Biobank study for early-stage breast cancer samples
This study collects and stores biological samples (like tissue or blood) from people with early-stage breast cancer to help future research. It’s mainly for people with a specific type of early breast cancer called high-grade DCIS.
Stavanger, RogalandAges 18–85 - NCT04399876Enrolling by invitationPhase 1
Testing an implantable device to study drug response in prostate cancer
This early-phase study uses a tiny implant placed during prostate cancer surgery planning to help researchers measure how tumors respond to treatment while still in the body. The results may help improve future treatment choices for men with intermediate- or high-risk prostate cancer.
Boston, MassachusettsAges 22 years+ - NCT04361370Enrolling by invitationPhase 2
Olaparib plus pembrolizumab and bevacizumab after ovarian cancer
This trial tests whether adding olaparib, pembrolizumab, and bevacizumab as ongoing (“maintenance”) treatment can help control platinum-sensitive recurrent ovarian, fallopian tube, or primary peritoneal cancer that has responded to prior chemotherapy. It focuses on people whose tumors do NOT have BRCA1/2 gene mutations.
SeoulAges 20 years+ - NCT04254133Enrolling by invitation
Study uses genetics to guide prostate cancer care and screening
This study collects saliva and health/family history information to learn how inherited (genetic) factors relate to prostate cancer. The goal is to improve how treatment and future screening are planned for people and families.
Seattle, WashingtonAges 35–89 - NCT04165460Enrolling by invitation
CBT programs for anxiety and coping in cervical cancer
This study tests two structured talk-therapy programs (cognitive-behavioral therapy) to help people with cervical cancer manage anxiety, depression symptoms, and unhelpful coping skills. It also looks at the role of a main caregiver during care planning and support.
Mexico City, TlalpanAges 18 years+ - NCT04149613Enrolling by invitation
Blood marker study for new stage IV colon cancer
This study looks at blood tests (inflammatory markers and small RNA molecules called microRNAs) to better predict how stage IV colon cancer may progress. It may help doctors identify who is likely to do better or worse and tailor future care.
BeirutAges 18 years+ - NCT04098640Enrolling by invitation
Testing tumor DNA in younger people with metastatic breast cancer
This study looks at your tumor’s molecular (DNA/biologic) features to better understand metastatic breast cancer in people under 50. You may help researchers by providing tissue samples (biopsies) for lab testing.
Seoul, SeoulAges 19–50 - NCT03459820Enrolling by invitationPhase 2/Phase 3
PET/CT scan study for high-risk or returning prostate cancer
This trial studies how a special PET/CT scan (using 18F-DCFPyL) helps evaluate prostate cancer that is either high-risk at diagnosis or has come back based on PSA blood tests. It may help your care team better stage (map) the cancer and guide next steps.
Montreal, QuebecAges 18 years+ - NCT03393962Enrolling by invitationPhase 1/Phase 2
Antigen-targeted immune cell treatment for high-risk ovarian cancer
This early-phase trial tests a lab-made immune cell treatment designed to recognize ovarian cancer and attack it. It may help people with high-risk ovarian cancer who still need effective options.
Shenzhen, GuangdongAges 10–80 - NCT03025477RecruitingPhase 2
Testing two first-treatment options for advanced ovarian cancer
This Phase 2 trial compares two different treatment strategies as the first chemotherapy after surgery for advanced epithelial ovarian, peritoneal, or fallopian-tube cancer. It may help doctors find a more effective or better-tolerated approach for people in your situation.
DijonAges 18–75 - NCT00471978Recruiting
Analyzing DNA from blood and lung tumor tissue
This study looks at DNA from blood samples and lung tumor tissue in people newly diagnosed with primary lung cancer. The goal is to learn more about the cancer’s biology and possibly guide better future care.
Boston, MassachusettsAges 18–120 - NCT07802405RecruitingPhase 1
Testing a new drug alone or with ruxolitinib for myelofibrosis
This trial is testing a new drug called WJ01024, which may help treat myelofibrosis. It can be taken alone or with ruxolitinib, a standard treatment for this condition. The study checks safety and how well it works.
Zhengzhou, HenanAges 3 weeks+ - NCT07007975Enrolling by invitation
Web-based education for gynecological cancer awareness
This study tests a web-based program to help women learn about gynecological cancers and adopt healthier habits. If you're an adult woman with internet access and no personal or family history of these cancers, you may be able to join.
MalatyaAges 20–65
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for cancer?
- Yes. Clin2 currently lists 13,118 recruiting cancer studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a cancer trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a cancer trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Beyond the search
We also like to point to nonprofits doing real good in this area. We aren’t affiliated with them — we just admire the work.
- Stand Up To CancerPeople facing cancer across many types, through the research that leads to better treatments.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.